Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

169-180 of 2022 results
Page 15 of 169
Key Publications March 4, 2022

Fenofibrate use is associated with lower mortality and fewer cardiovascular events in patients with diabetes: Results of 10,114 patients from the Korean National Health insurance service cohort.

Diabetes Care. 2021;44:1868-1876

Jo SH, Nam H, Lee J, Park S, Lee J, Kyoung DS
Cardiovascular Disease Diabetes Lipids/Lipoproteins
Key Publications March 3, 2022

High consumption of ultra-processed food is associated with incident dyslipidemia: A prospective study of older adults.

J Nutr. 2021;151:2390-2398

Donat-Vargas C, Sandoval-Insausti H, Rey-García J, Moreno-Franco B, Åkesson A, Banegas JR, Rodríguez-Artalejo F, Guallar-Castillón P
Age Lipids/Lipoproteins Nutrition
Key Publications March 3, 2022

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges.

Heart. 2021;107:1369-1375

Packard C, Chapman MJ, Sibartie M, Laufs U, Masana L
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications March 2, 2022

Evidence for beneficial associations between isoenergetic macronutrient exchanges and serum non-HDL cholesterol, a measure of all circulating atherogenic, apoB-containing lipoproteins.

J Nutr. 2021;151:2096-2098

Griffin BA, Lovegrove JA
Cardiovascular Disease Lipids/Lipoproteins Nutrition
Key Publications March 2, 2022

Dietary macronutrient composition in relation to circulating HDL and non-HDL cholesterol: A federated individual-level analysis of cross-sectional data from adolescents and adults in 8 European studies.

J Nutr. 2021;151:2317-2329

Pinart M, Jeran S, Boeing H, Stelmach-Mardas M, Standl M, Schulz H, Harris C, von Berg A, Herberth G, Koletzko S et al.
Cardiovascular Disease Lipids/Lipoproteins Nutrition
Key Publications March 2, 2022

CUN-BAE index as a screening tool to identify increased metabolic risk in apparently healthy normal-weight adults and those with obesity.

J Nutr. 2021;151:2215-2225

Costa A, Konieczna J, Reynés B, Martín M, Fiol M, Palou A, Romaguera D, Oliver P
Ectopic Fat Insulin Resistance Lipids/Lipoproteins
Key Publications March 1, 2022

The residual risk odyssey: From LDL to Lp(a).

J Am Coll Cardiol. 2021;78:434-436

Rosenson RS, Goonewardena SN
Acute Coronary Syndromes Cardiovascular Disease Lipids/Lipoproteins
Key Publications February 28, 2022

Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol.

J Am Coll Cardiol. 2021;78:421-433

Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P, ODYSSEY Outcomes Committees and Investigators
Acute Coronary Syndromes Cardiovascular Disease Lipids/Lipoproteins
Key Publications February 25, 2022

Diverging trends for onset of acute myocardial infarction, heart failure, stroke and mortality in young males: role of changes in obesity and fitness.

J Intern Med. 2021;290:373-385

Åberg ND, Adiels M, Lindgren M, Nyberg J, Georg Kuhn H, Robertson J, Schaufelberger M, Sattar N, Åberg M, Rosengren A
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications February 25, 2022

Lipoprotein(a) and cardiovascular diseases.

JAMA. 2021;326:352-353

Miksenas H, Januzzi JL Jr, Natarajan P
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications February 24, 2022

Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status.

Atherosclerosis. 2021;330:29-35

Liu HH, Li S, Cao YX, Guo YL, Zhu CG, Wu NQ, Li JJ
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications February 23, 2022

Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: Data from a randomized, placebo-controlled study.

Atherosclerosis. 2021;330:8-13

Rau M, Thiele K, Korbinian Hartmann NU, Möllmann J, Wied S, Böhm M, Scharnagl H, März W, Marx N, Lehrke M
Cardiovascular Disease Diabetes Lipids/Lipoproteins
of 169